/Investor DB

Gurnet Point Capital

Pre-Seed–Seed · 3 people tracked

Find your way into Gurnet Point Capital

Each arrow is one introduction. Sign up to fill in the first one.

1,590 people can intro you to Michael

Ask Yusuke Okada to introduce you to Michael Bucella

You →Yusuke · together at Neoclassic Capital →Michael

177 people can intro you to Sally

Ask Jamie Chen to introduce you to Sally Tennant

You →Jamie · together at Acorn Capital Advisers →Sally

27 people can intro you to Matheus

Ask Sam Okafor to introduce you to Matheus Bonifácio

You →Sam · together at Kli Capital →Matheus

Sign up to find every way you can get introduced to Gurnet Point Capital

  • Your email: who you already know at Gurnet Point Capital, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gurnet Point Capital team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

B-FLEXION invests across transformative industries with a particular focus on life sciences. The firm conducts seed investments, acquires operating businesses, and develops strategic partnerships while maintaining a dedicated practice for biopharma, diagnostics, and innovative healthcare service providers.

Invests inBiotechHealthtechMedical DevicesSector Agnostic

Source: firm website, verified Jul 21, 2026.

Stage
Pre-Seed–Seed
Instruments
Equity
Tracked investments
4

Team · 3 people

from curated

What they invest in

from 4 of 4 portfolio companies

Biotech ×4Healthtech ×2Data & Infrastructure ×1Digital Health ×1Medical Devices ×1

HQs:United States×4

Investments · 4 tracked

founders shown can be your intro path

By year:2022 · 12018 · 12016 · 12012 · 14 dated

Macrolide PharmaceuticalsinApr 2018 · $20M

BiotechWatertown, US

Edward Mascioli(Executive Officer)Andrew Myers(Director)

BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in

Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund

Naverisnaveris.comin𝕏Sep 2022 · $51M

Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US

James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)

BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)

Co-investorsBrightEdgeTechU Ventures

Tremeau Pharmaceuticalstremeau.cominOct 2016

Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs.

BiotechHealthtechCambridge, US

Bradford C. Sippy(Executive Officer, Director)Benjamin Enerson(Executive Officer)Mark Corrigan(Executive Officer)in

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Innocoll Holdings

Frequently asked questions

What stage does Gurnet Point Capital invest at?
Gurnet Point Capital invests at the Pre-Seed, Seed stages.
What sectors does Gurnet Point Capital focus on?
Gurnet Point Capital focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.

Similar investors

Featured in lists